Aerie Em

06/03/2020

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

  June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of […]
05/26/2020

Present & Future of Vaccine Development seminar series: The architecture of SARS-CoV-2 genome with Prof. V. Narry Kim

May 22, 2020, SEOUL, South Korea — For our first lecture in our ‘Present and Future of Vaccine Development’ series of 2020, we welcomed Professor V. Narry Kim from Seoul National University to present on the SARS-CoV-2 (the virus causing COVID-19) genome and its transcriptomic architecture. […]
05/25/2020

IVI standardizes on Veeva Vault QualityDocs to Improve Operational Efficiency

SEOUL, KOREA — March 10, 2020 — Veeva Systems (NYSE:VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real […]
05/24/2020

Development Today | Why Sweden funds a vaccine institute in Korea and not Oslo-based CEPI